V

Vaxcyte

164 employees

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biopharma

Date founded

2013

Funding rounds raised

Total raised

$110M

from 16 investors over 16 rounds

V

Vaxcyte raised $3.2M on August 5, 2021

Investors: CARB-X

V

Vaxcyte raised $2.7M on December 1, 2020

Investors: CARB-X

V

Vaxcyte raised $110M on March 6, 2020

Investors: Longitude Capital, Foresite Capital, Frazier Healthcare Partners, Medicxi and RA Capital Management, L.P.

V

Vaxcyte raised $1.6M on June 1, 2019

Investors: CARB-X

V

Vaxcyte raised $85M on June 7, 2018

Investors: Abingworth, Foresite Capital and Medicxi

V

Vaxcyte raised $60M on March 21, 2017

Investors: Longitude Capital, Frazier Healthcare Partners and Abingworth

V

Vaxcyte raised $22M on July 23, 2015

Investors: Abingworth and Longitude Capital

FAQ